Published in Journal of Clinical Investigation · View the paper (DOI)
Researchers at EMBL found that residual breast cancer cells have specific traits that distinguish them from healthy cells and seem to cause relapse. The study suggests lipid metabolism as an exciting therapeutic target to reduce breast cancer recurrence.
Coverage from 2 institutions
- Cell changes drive breast cancer relapse European Molecular Biology Laboratory · May 15, 2017 · first to report
- Metabolic peculiarities betray the identity of relapse-causing breast cancer cells JCI Journals · May 15, 2017